Wall Street Jedi
  • About us
  • Contact us
  • Privacy Policy
  • Terms & Conditions
  • News
  • Economy
  • Editor’s Pick
  • Investing
  • Stock
No Result
View All Result
  • News
  • Economy
  • Editor’s Pick
  • Investing
  • Stock
No Result
View All Result
Wall Street Jedi
No Result
View All Result
Home Investing

US drops appeal in case over UnitedHealth Medicare plans’ rating

by
January 24, 2025
in Investing
0
US drops appeal in case over UnitedHealth Medicare plans’ rating
0
SHARES
3
VIEWS
Share on FacebookShare on Twitter

By Brendan Pierson

(Reuters) – The U.S. Centers for Medicare and Medicaid Services on Friday said it would not appeal a court order that it recalculate the public star ratings it gave to UnitedHealth’s privately administered Medicare health insurance plans, which the insurer said would cost it millions of dollars from lost customers.

The agency did not give a reason for withdrawing the notice of appeal it had filed just three days earlier. It was not clear whether the move was part of a broader policy change by President Donald Trump’s new administration.

CMS declined to comment, citing a pause on public communications by health agencies ordered by the Trump administration. UnitedHealth did not immediately respond to a request for comment.

The lawsuit concerns UnitedHealth’s Medicare Advantage plans, which are privately administered health insurance plans funded by the federal Medicare program for those age 65 and older and some Americans with disabilities.

CMS assigns Medicare Advantage plans ratings of one to five stars to help consumers choose among plans. UnitedHealth said in its lawsuit that some of its Medicare Advantage plans lost half a star because of a single unsuccessful call placed by a CMS test caller seeking a foreign language interpreter.

UnitedHealth said that CMS was arbitrary and capricious in docking the star ratings on the basis of a single call, and said that an error by the test caller was responsible for failing to connect with a representative.

A Texas federal judge in November agreed and ordered CMS to recalculate the star rating.

Other insurers, including Elevance, Centene (NYSE:CNC) and Humana (NYSE:HUM), have also sued CMS over what they allege are unfair star ratings.

CMS previously recalculated star ratings for Elevance and non-profit SCAN Health Plans’ Medicare Advantage plans after losing court rulings.

UnitedHealth Group (NYSE:UNH) shares were up about 0.6% at $532.86.

This post appeared first on investing.com
Previous Post

VIX drops as market shrugs off tariff concerns

Next Post

Dollar experiences steepest one-week drop since July 2023

Next Post
Dollar experiences steepest one-week drop since July 2023

Dollar experiences steepest one-week drop since July 2023

  • Trending
  • Comments
  • Latest
American creating deepfakes targeting Harris works with Russian intel, documents show

American creating deepfakes targeting Harris works with Russian intel, documents show

October 23, 2024
Cadence raises midpoint of 2024 profit forecast on robust demand from chip designers

Cadence raises midpoint of 2024 profit forecast on robust demand from chip designers

October 28, 2024
Earnings call: Microsoft sees soaring cloud and AI growth in Q1 FY2025

Earnings call: Microsoft sees soaring cloud and AI growth in Q1 FY2025

October 31, 2024
Israel stocks lower at close of trade; TA 35 down 0.23%

Israel stocks lower at close of trade; TA 35 down 0.23%

October 6, 2024
Is a Chinese chain’s blood orange cold brew the future of coffee in America?

Is a Chinese chain’s blood orange cold brew the future of coffee in America?

0
Retailers scramble to move billions in cargo as East Coast dockworkers prepare to strike

Retailers scramble to move billions in cargo as East Coast dockworkers prepare to strike

0
PepsiCo to buy tortilla chip maker Siete Foods for $1.2 billion

PepsiCo to buy tortilla chip maker Siete Foods for $1.2 billion

0
East and Gulf coast ports shut down as thousands of workers go on strike

East and Gulf coast ports shut down as thousands of workers go on strike

0
Is a Chinese chain’s blood orange cold brew the future of coffee in America?

Is a Chinese chain’s blood orange cold brew the future of coffee in America?

July 7, 2025
Essence Fest leads a summer of events for Black entrepreneurs galvanized by economic uncertainty

Essence Fest leads a summer of events for Black entrepreneurs galvanized by economic uncertainty

July 4, 2025
Tariffs and weaker beer demand are weighing on Modelo owner Constellation Brands

Tariffs and weaker beer demand are weighing on Modelo owner Constellation Brands

July 3, 2025
Microsoft laying off about 9,000 employees in latest round of cuts

Microsoft laying off about 9,000 employees in latest round of cuts

July 3, 2025

Recent News

Is a Chinese chain’s blood orange cold brew the future of coffee in America?

Is a Chinese chain’s blood orange cold brew the future of coffee in America?

July 7, 2025
Essence Fest leads a summer of events for Black entrepreneurs galvanized by economic uncertainty

Essence Fest leads a summer of events for Black entrepreneurs galvanized by economic uncertainty

July 4, 2025
Tariffs and weaker beer demand are weighing on Modelo owner Constellation Brands

Tariffs and weaker beer demand are weighing on Modelo owner Constellation Brands

July 3, 2025
Microsoft laying off about 9,000 employees in latest round of cuts

Microsoft laying off about 9,000 employees in latest round of cuts

July 3, 2025

Disclaimer: WallStreetJedi.com, its managers, its employees, and assigns (collectively "The Company") do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

  • About us
  • Contact us
  • Privacy Policy
  • Terms & Conditions

Copyright © 2025 wallstreetjedi.com | All Rights Reserved

No Result
View All Result
  • News
  • Economy
  • Editor’s Pick
  • Investing
  • Stock

Copyright © 2025 wallstreetjedi.com | All Rights Reserved